Journal News

Scientists find unexpected correlation between age and HDL-C levels

Jessica Desamero
June 3, 2025

Coronary heart disease, or CHD, is a type of heart disease in which coronary arteries can’t deliver enough oxygen-rich blood to the heart, causing chest pain, shortness of breath and potentially a heart attack. High-density lipoprotein cholesterol, or HDL-C, also known as “good” cholesterol, levels are a risk indicator of CHD. Naturally high HDL-C levels reduce the risk of CHD, while low HDL-C levels increase this risk.

In a recent Journal of Lipid Research study, researchers determined how various factors, such as age, physical activity and childbirth, predict HDL-C serum concentration in a large, diverse cohort of adults. This multicenter study is one of the few to analyze HDL-C over an extended period, over 30 years, rather than only one time point.

Scientific Animations

The Coronary Artery Risk Development in Young Adults study, or CARDIA, began in 1985 with a group of 5,115 Black and white men and women, aged 18–30 years, across multiple U.S. sites. James M. Shikany and his team led the coordinating center for the study at the University of Alabama at Birmingham. CARDIA examines the risk factors of CHD. Since then, Shikany has expanded the study to examine factors associated with HDL-C.

Participants receive tests and respond to questionnaires every five years to measure these factors. Shikany and his team then examine patterns in physical measurements, lifestyle factors, behavioral and psychological variables, medical and family history and blood concentrations of relevant substances. They then performed statistical regression analyses on the data. In their study, the team tested additional variables associated with HDL-C, including menopause status, hormone therapy and use of prescription drugs that lower cholesterol levels. Shikany said previous studies rarely examined these variables.

“I started noticing over the years that the HDL-C (serum levels) in CARDIA in men and women has been rising since year 15,” Shikany said. “(T)hat just piqued my interest.”

Shikany said this observation puzzled him because most participants showed higher weights, a characteristic usually associated with lower HDL-C levels.

The team observed that HDL-C levels positively correlated with age, alcohol intake, hormone therapy and birth control use and physical activity. Moreover, they found that individuals who had given birth had lower HDL-C levels than those who had not, with an even stronger correlation amongst those that birthed three or more children. Other factors associated with lower HDL-C concentrations include smoking and BMI.

Several questions remain, as the researchers did not identify one main factor driving the increased HDL-C levels. Shikany said age may be the driving factor, however, more research is needed to confirm that hypothesis.

Future directions will explore additional factors that may impact HDL-C levels and examine details of patient HDL-C, such as subtypes and functionality.

CARDIA is ongoing, and its duration will soon reach 40 years. Shikany said he hopes that the study will continue for many more years, allowing researchers to determine additional factors that influence cholesterol levels.

“We’ve always had very good retention; about 70% of the surviving cohorts come back for each exam,” Shikany said. “It’s really remarkable and shows their dedication, so we want to always express our appreciation.”

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Jessica Desamero

Jessica Desamero is a graduate of the biochemistry Ph.D. program at the City University of New York Graduate Center and an ASBMB volunteer contributor.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Disease-linked mutations disrupt protein phase behavior
Journal News

Disease-linked mutations disrupt protein phase behavior

April 9, 2026

Researchers find that pathogenic missense mutations are enriched threefold in phrase-separating intrinsically disordered regions of proteins.

The dual role of asprosin in chronic fatty liver disease
Journal News

The dual role of asprosin in chronic fatty liver disease

April 8, 2026

Researchers uncover a hormone called asprosin that may serve as a potential biomarker for the diagnosis of chronic fatty liver disease and monitoring disease progression.

Novel inhibitor targets RAS-driven cancers
Journal News

Novel inhibitor targets RAS-driven cancers

April 7, 2026

Researchers in Louisville identify a small-molecule drug that blocks RALGEF signaling downstream of mutant RAS. The compound suppresses tumor growth with low toxicity, revealing a new therapeutic strategy for RAS-driven malignancies.

Catching tau in the act
Journal News

Catching tau in the act

April 2, 2026

Using a new proximity-labeling approach, researchers reveal how tangles of the brain-associated protein tau may disrupt RNA biology long before neurons die.

How copper delivery fuels bacterial respiration
Journal News

How copper delivery fuels bacterial respiration

April 1, 2026

Researchers identify the roles of several proteins in copper homeostasis in the aerobic bacterium Caulobacter vibrioides.

Revealing the glycoproteome of a cancer subtype
Journal News

Revealing the glycoproteome of a cancer subtype

March 31, 2026

Researchers mapped the glycoproteome of extrahepatic cholangiocarcinoma and compared it to intrahepatic tumors. Differences in sugar modifications and immune cell content suggest new biomarkers and guide development of targeted immunotherapies.